Advertisement

U.S. markets open in 4 hours 20 minutes

S&P Futures
4,273.75
-3.00(-0.07%)
Dow Futures
33,942.00
-21.00(-0.06%)
Nasdaq Futures
13,477.00
-16.25(-0.12%)
Russell 2000 Futures
1,990.10
+1.00(+0.05%)
Crude Oil
89.27
+1.16(+1.32%)
Gold
1,780.00
+3.30(+0.19%)

Advertisement

Eton Pharmaceuticals, Inc. (ETON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

2.4300

+0.0600

(+2.53%)

At close: 04:00PM EDT

2.3700

-0.06

(-2.47%)

After hours:

05:54PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Commodity Channel Index

View all chart patterns

Performance Outlook

Previous Close	2.3700
Open	2.3700
Bid	0.0000 x 3000
Ask	0.0000 x 800
Day's Range	2.3501 - 2.4700
52 Week Range	2.3500 - 6.7200
Volume	269,104
Avg. Volume	205,527

Market Cap	61.472M
Beta (5Y Monthly)	1.37
PE Ratio (TTM)	N/A
EPS (TTM)	-0.4880
Earnings Date	Nov 14, 2022 - Nov 21, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	9.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ETON

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Eton Pharmaceuticals, Inc.
Daily – Vickers Top Buyers & Sellers for 07/06/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
last monthArgus Research

All

Zacks
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -300% and 5.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 4 Reasons to Add York Water (YORW) to Your Portfolio Now
  Zacks
- Green Power (GP) Q1 Loss Wider Than Expected, Revenues Rise
  Zacks
GlobeNewswire
Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results
Total Q2 2022 revenue of $7.4 million, up 139% from prior yearRecently launched ALKINDI SPRINKLE® and Carglumic Acid continue to show robust growthDivestiture of hospital products division to focus on rare disease strategyU.S. Food and Drug Administration (FDA) Approval of Zonisade™ (zonisamide oral suspension) DEER PARK, Ill., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for
Zacks
Analysts Estimate Fortress Biotech (FBIO) to Report a Decline in Earnings: What to Look Out for
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.